Cong‐Fei Xu
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
-
- RNA Interference and Gene Delivery 24
- Advanced biosensing and bioanalysis techniques 9
-
- Nanoplatforms for cancer theranostics 14
- Graphene and Nanomaterials Applications 6
- Co-authors
- Jun Wang (50 shared papers)Xianzhu Yang (17 shared papers)Song Shen (23 shared papers)Yang Liu (11 shared papers)Zhiting Cao (11 shared papers)Xiao‐Jiao Du (13 shared papers)Hongjun Li (5 shared papers)Ying‐Li Luo (14 shared papers)
- Journals
- Biomaterials (7 papers)Nature Communications (6 papers)Biomaterials Science (5 papers)ACS Nano (5 papers)Nano Today (4 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Cong‐Fei Xu
62 papers receiving 4.6k citations
Cong‐Fei Xu's Hit Papers
Peers
Comparison fields: 5 of 102
- Biomaterials 1.3k
- Immunology 824
- Biomedical Engineering 1.8k
- Molecular Biology 2.5k
- Oncology 574
Countries citing papers authored by Cong‐Fei Xu
This map shows the geographic impact of Cong‐Fei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong‐Fei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong‐Fei Xu more than expected).
Fields of papers citing papers by Cong‐Fei Xu
This network shows the impact of papers produced by Cong‐Fei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong‐Fei Xu. The network helps show where Cong‐Fei Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong‐Fei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy Hit paper breakdown → | 2016 | 670 |
| 2 | 2015 | 320 | |
| 3 | 2017 | 292 | |
| 4 | 2018 | 200 | |
| 5 | 2014 | 187 | |
| 6 | 2016 | 184 | |
| 7 | 2018 | 174 | |
| 8 | 2019 | 163 | |
| 9 | 2015 | 156 | |
| 10 | 2014 | 155 | |
| 11 | 2015 | 126 | |
| 12 | 2020 | 120 | |
| 13 | 2017 | 119 | |
| 14 | 1990 | 116 | |
| 15 | 2016 | 102 | |
| 16 | 2016 | 102 | |
| 17 | 2018 | 95 | |
| 18 | 2021 | 93 | |
| 19 | 2018 | 89 | |
| 20 | 2019 | 81 |
About Cong‐Fei Xu
Cong‐Fei Xu is a scholar working on Molecular Biology, Biomedical Engineering, Immunology, Oncology and Biomaterials, having authored 66 papers that have together received 4.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (24 papers), Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (14 papers), Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (11 papers), Advanced biosensing and bioanalysis techniques (9 papers), Immune Cell Function and Interaction (7 papers) and Graphene and Nanomaterials Applications (6 papers). The work is most often cited by research in Biomaterials (1.3k citations), Immunology (824 citations), Biomedical Engineering (1.8k citations), Molecular Biology (2.5k citations) and Oncology (574 citations). Cong‐Fei Xu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jun Wang, Xianzhu Yang, Song Shen, Yang Liu, Zhiting Cao, Xiao‐Jiao Du, Hongjun Li, Ying‐Li Luo, Jin‐Zhi Du and Zi-Dong Lu. Their work appears in journals such as Biomaterials, Nature Communications, Biomaterials Science, ACS Nano and Nano Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.